Ishita Drugs & Indus

ISHITADR

SectorHealthcare

‌
‌
‌
‌
‌
‌
‌
‌

‌

‌
‌

‌
‌
‌

‌
‌

‌

‌
‌
‌
‌
‌
‌
‌

‌
‌
‌
‌
‌
‌

Ishita Drugs & Indus Stock Price - ₹72.70 | Healthcare | askfuzz

ISHITADR

SectorHealthcare

‌
‌
‌
‌
‌
‌
‌
‌

Exchange filings, newest first

Results, presentation and transcript tracked for every quarter

Quarterly Result Q1 FY2026-27

7 pages

Management Discussion, Balance Sheet and more

Annual Reports 2025-26

12 pages

Annual Reports 2024-25

49 pages

Annual Reports 2023-24

53 pages

KMP changes, governance and LODR disclosures

DateFilingCategory

2 Oct 2026Ishita Drugs & Industries Ltd discloses voting results and scrutinizer's report for 33rd AGM held on 30 Sep 2026Record Date

2 Oct 2026Ishita Drugs & Industries Ltd re-appoints M/s. Jaymin Shah & Associates as Statutory Auditors for FY27KMP

2 Oct 2026Ishita Drugs & Industries Ltd re-appoints Mrs. Abha Agrawal as Non-Executive Non-Independent Director on 02 Oct 2026KMP

30 Sept 2026Ishita Drugs & Industries Ltd outcome of 33rd AGM held on 30 Sep 2026 approving FY26 results and auditor appointmentRecord Date

28 Aug 2026Ishita Drugs & Industries Ltd submission of annual report for FY26 along with notice of 33rd AGMRecord Date

27 Aug 2026Ishita Drugs & Industries Ltd record date for e-voting for AGM on 23 Sep 2026Record Date

27 Aug 2026Ishita Drugs & Industries Ltd AGM scheduled on 30 Sep 2026Record Date